GLP-1 Medication Services Are Driving Medspa and Aesthetic Physician Office Revenue Growth

GLP-1 medications now contribute approximately 15% of monthly revenue at practices offering them, according to the data.
GLP-1 medications now contribute approximately 15% of monthly revenue at practices offering them, according to the data.
Марина Демешко at Adobe Stock

Recent data from Guidepoint Qsight reveals that GLP-1 medications for weight loss has reshaped the aesthetics market.Recent data from Guidepoint Qsight reveals that GLP-1 medications for weight loss has reshaped the aesthetics market.Courtesy of Qsight Market ViewRecent data from Guidepoint Qsight reveals that GLP-1 medications for weight loss has reshaped the aesthetics market, with revenue at practices offering GLP-1 treatments increasing by an average of 9%, compared to a 2% decline at practices that did not offer these drugs.

Log in to view the full article
More in Practice Management